UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 817

Sortiert nach

Pharmacogenetics to Avoid Adverse Drug Reactions

Journal of personalized medicine, 2022-01, Vol.12 (2), p.159

López-Fernández, Luis A

2022

Volltextzugriff (PDF)

Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn's Disease

International journal of molecular sciences, 2020-01, Vol.21 (2), p.676

2020

Volltextzugriff (PDF)

Distinct Gene Expression Profiling after Infection of Immature Human Monocyte-Derived Dendritic Cells by the Attenuated Poxvirus Vectors MVA and NYVAC

Journal of Virology, 2007-08, Vol.81 (16), p.8707-8721

2007

Volltextzugriff (PDF)

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease

Pharmaceutics, 2021-10, Vol.13 (11), p.1786

2021

Volltextzugriff (PDF)

Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

Pharmacogenomics, 2012-07, Vol.13 (10), p.1173-1191

2012

Volltextzugriff (PDF)

Microarray Analysis Reveals Characteristic Changes of Host Cell Gene Expression in Response to Attenuated Modified Vaccinia Virus Ankara Infection of Human HeLa Cells

Journal of Virology, 2004-06, Vol.78 (11), p.5820-5834

2004

Volltextzugriff (PDF)

Selective Induction of Host Genes by MVA-B, a Candidate Vaccine against HIV/AIDS

Journal of Virology, 2010-08, Vol.84 (16), p.8141-8152

2010

Volltextzugriff (PDF)

Identification of new SNPs associated with severe toxicity to capecitabine

Pharmacological research, 2017-06, Vol.120, p.133-137

2017

Volltextzugriff (PDF)

Genomic Profiling of Circulating Plasma RNA for the Analysis of Cancer

Clinical chemistry (Baltimore, Md.), 2007-10, Vol.53 (10), p.1860-1863

2007

Volltextzugriff (PDF)

Cellular Gene Expression Survey of Vaccinia Virus Infection of Human HeLa Cells

Journal of Virology, 2003-06, Vol.77 (11), p.6493-6506

2003

Volltextzugriff (PDF)

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Pharmacological research, 2023-08, Vol.194, p.106859-106859, Article 106859

2023

Volltextzugriff (PDF)

Human gene profiling in response to the active protein kinase, interferon-induced serine/threonine protein kinase (PKR), in infected cells. Involvement of the transcription factor ATF-3 IN PKR-induced apoptosis

The Journal of biological chemistry, 2006-07, Vol.281 (27), p.18734-18745

2006

Volltextzugriff (PDF)

Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Pharmacological research, 2023-10, Vol.196, p.106938-106938, Article 106938

2023

Volltextzugriff (PDF)

Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment

Biomedicine & pharmacotherapy, 2024-04, Vol.173, p.116299-116299, Article 116299

2024

Volltextzugriff (PDF)

Using pharmacogenetics to prevent severe adverse reactions to capecitabine

Pharmacogenomics, 2017-08, Vol.18 (13), p.1199-1213

2017

Volltextzugriff (PDF)

Genetic Predictors of Long‐term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease

Journal of pediatric gastroenterology and nutrition, 2020-10, Vol.71 (4), p.508-515

2020

Volltextzugriff (PDF)

ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics

Journal of personalized medicine, 2018-12, Vol.8 (4), p.40

López-Fernández, Luis A

2018

Volltextzugriff (PDF)

Host Response to the Attenuated Poxvirus Vector NYVAC: Upregulation of Apoptotic Genes and NF-κB-Responsive Genes in Infected HeLa Cells

Journal of Virology, 2006-01, Vol.80 (2), p.985-998

2006

Volltextzugriff (PDF)

Pharmacogenetics to Avoid Adverse Drug Reactions

López-Fernández, Luis A

2022

Volltextzugriff (PDF)

Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan

Pharmacological research, 2018-10, Vol.136, p.133-139

2018

Volltextzugriff (PDF)

Gene Therapy in HIV-Infected Cells to Decrease Viral Impact by Using an Alternative Delivery Method

ChemMedChem, 2010-06, Vol.5 (6), p.921-929

2010

Volltextzugriff (PDF)

1 – 25 von 817

Suche als RSS-Feed

Aktive Filter

SpracheFranzösisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(668)
Mit Volltextzugriff
(745)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(418)
Life Sciences & Biomedicine
(333)
Humans
(242)
Male
(153)
Female
(147)
Middle Aged
(91)
Adult
(77)
Physical Sciences
(71)
Aged
(64)
Technology
(55)
Biological And Medical Sciences
(49)
Cardiovascular System & Cardiology
(48)
Cardiac & Cardiovascular Systems
(47)
Chemistry
(45)
Spain
(44)
Public, Environmental & Occupational Health
(42)
Animals
(40)
Infectious Diseases
(40)
Health Care Sciences & Services
(37)
Pharmacology & Pharmacy
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Pharmacogenetics to Avoid Adverse Drug Reactions

Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn's Disease

Distinct Gene Expression Profiling after Infection of Immature Human Monocyte-Derived Dendritic Cells by the Attenuated Poxvirus Vectors MVA and NYVAC

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease

Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12

Microarray Analysis Reveals Characteristic Changes of Host Cell Gene Expression in Response to Attenuated Modified Vaccinia Virus Ankara Infection of Human HeLa Cells

Selective Induction of Host Genes by MVA-B, a Candidate Vaccine against HIV/AIDS

Identification of new SNPs associated with severe toxicity to capecitabine

Genomic Profiling of Circulating Plasma RNA for the Analysis of Cancer

Cellular Gene Expression Survey of Vaccinia Virus Infection of Human HeLa Cells

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort

Human gene profiling in response to the active protein kinase, interferon-induced serine/threonine protein kinase (PKR), in infected cells. Involvement of the transcription factor ATF-3 IN PKR-induced apoptosis

Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment

Using pharmacogenetics to prevent severe adverse reactions to capecitabine

Genetic Predictors of Long‐term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease

Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease

ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics

Host Response to the Attenuated Poxvirus Vector NYVAC: Upregulation of Apoptotic Genes and NF-κB-Responsive Genes in Infected HeLa Cells

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease

Pharmacogenetics to Avoid Adverse Drug Reactions

Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan

Gene Therapy in HIV-Infected Cells to Decrease Viral Impact by Using an Alternative Delivery Method

Aktive Filter

Suchergebnisse filtern